All news articles for July 2014

MYO-X, the company's consumer product, is a granular, sweetened powder that is consumed by the spoonful.

MYOS Corp. grows market for myostatin inhibitor beyond the gym

By Hank Schultz

Myos Corporation has built the market for its myostatin-inhibiting ingredient Fortetropin beyond the gym and into the offices of physician groups treating elderly patients. To secure the supply for the ingredeint the company has extending a manufacturing...

Herbalife misses profit estimates, share price plunges

Herbalife misses profit estimates, share price plunges

By Hank Schultz

Herbalife's share price dropped sharply yesterday as the company reported second quarter earnings that missed analysts’ estimates.  Shares dropped 11% almost immediately on the news and declined further in early trading today, with a share price...

Alternative products sans DMAA have not filled the gap in sales created when the ingredient was removed from the market, GNC CEO says.

Supplement market headwinds beset GNC as earnings decline in Q2

By Hank Schultz

The past year has been a tough one for the sales of dietary supplements, and retailing giant GNC is not immune to those trends.  In the company’s second quarter 2014 earnings GNC reported declines in both overall revenue and net income year-over-year.

Protein: the bridge to fitness for the rest of us

By Maggie Hennessy

We have become a nation of fitness and nutrition go-getters, as evidenced by the skyrocketing number of fitness and nutrition apps and the mainstreaming of the sports nutrition market.